2 completed, 2 terminated. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Completed 2, Terminated 2 |
Follow mycophenolate mofetil (MMF): new trials by email Literature Review of mycophenolate mofetil (MMF) trials Research Report on mycophenolate mofetil (MMF)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study Investigating the Renal Tolerability, Efficacy, and Safety of a CNI-free Versus a Standard Regimen in de Novo Heart Transplant (HTx) Recipients Everolimus (EVR), cyclosporine A (CyA), tacrolimus (TAC) - Heart Transplantation | Phase 4 | Completed | Novartis Pharmaceuticals | 162 | 2009-02-24 | 2018-08-07 |
| A Study Designed to Compare the Tolerability of an Increased Dose of Enteric-coated Mycophenolate Acid (MPA) in Renal Transplant Patients Whose Dose of Mycophenolate Mofetil (MMF) Was Reduced Due to Gastrointestinal Symptoms Enteric-coated Mycophenolate Acid (EC-MPA), Mycophenolate Mofetil (MMF), Placebo MMF - Renal Transplantation | Phase 4 | Terminated | Novartis Pharmaceuticals | 30 | 2008-03-01 | 2012-08-07 |
| Enteric-Coated Mycophenolate Sodium on Quality of Life in Patients With Gastrointestinal Symptoms Related to Mycophenolate Mofetil Therapy After Kidney Transplantation Enteric-Coated Mycophenolate Sodium (EC-MPS), Mycophenolate Mofetil (MMF) - Renal Transplant | Phase 4 | Completed | Novartis Pharmaceuticals | 134 | 2005-09-01 | 2017-03-30 |
| A Trial of Two Steroid-Free Approaches Toward Mycophenolate Mofetil-Based Monotherapy Immunosuppression Tacrolimus (TAC), Sirolimus, Alemtuzumab - Kidney Transplant Failure and Rejection | Phase 4 | Terminated | Northwestern University | 40 | 2005-04-01 | 2015-10-26 |
Novartis Pharmaceuticals (3) · Northwestern University (1)
United States (2) · Germany (1) · United Kingdom (1)
Joseph R Leventhal, MD, PhD (1) · Magdi Shehata, MBBCh, MD, FRCS (1)
2004 (1)